Company Announcements Oxford Nanopore licensed technology from the University of Cambridge for a hybrid nanopore that combines a solid state nanopore and DNA origami, which are small, well-controlled shapes made of DNA. Bloomberg reported that Illumina’s agreement related to Oxford Nanopore exonuclease sequencing technology will expire in 2016. Illumina holds a 15% stake in Oxford […]
Company Announcements Real Time Genomics and Omicia entered into a commercial partnership in April to deliver genomic analysis and interpretation, respectively, in a single workflow for the clinical interpretation of childhood diseases. The integrated product will be launched later this year. Life Technologies partnered with Ridom in April to make SeqSphere+ whole-genome bacterial typing software […]
Tokyo, Japan 7/8/13; Cambridge, UK 7/8/13—Hitachi High-Technologies and Base4 Innovation have announced a collaborative technology development agreement to develop a long read length, single molecule, nanopore-based DNA sequencer. Base4’s nanopore sequencing method increases the signal of unlabeled DNA passing through a nanopore by using laser light-enhanced gold structures. “For this nanopore sequencing system, Hitachi High-Tech […]
Company Announcements SynapDx formed a strategic relationship with Illumina for their respective autism technologies and sequencing platform to develop early detection tools for autism spectrum disorders. Susan Siegel resigned from Pacific Biosciences Board in March. Spiral Genetics closed a $3 million Series A financing in March and partnered with Omicia. Nabsys closed a $20 million […]
New York, NY 4/16/13—Bloomberg reported that Sigma-Aldrich was among the bidders for Life Technologies (see IBO 4/15/13), offering around $12.5 billion for the company. Sigma planned to sell the sequencer business if it acquired Life in order to help fund the transaction, according to the report. Sigma held talks with Roche and Agilent Technologies regarding […]
Company Announcements Pacific Biosciences 2012 revenue declined 23.3% to $26.0 million (see IBO 3/31/13), with Product revenue accounting for 77%. The number of systems delivered fell 52% to 23, bringing the total installed base to 71. The US, Asia and Europe accounted for 44%, 31% and 25% of revenues, respectively. As of December 2012, cash […]
As next-generation sequencing (NGS) becomes more popular in clinical settings, partnerships are forming to enable the application of this new technology for diagnostic applications. In January, two NGS firms announced partnerships with organizations with backgrounds in molecular diagnostics. Life Technologies announced a partnership with Boston Children’s Hospital (BCH) to establish Claritas Genomics, which will develop […]
The life science instrumentation (LSI) market is the largest technology sector, accounting for about a quarter of the total analytical instruments industry. It encompasses a broad spectrum of technologies grouped into 13 categories. Unlike most other instrument markets, the LSI market is heavily reliant on the aftermarket. Consumables, reagents, kits and other aftermarket products make […]
Aarhus, Denmark 9/3/12—CLC bio, a developer of software for next-generation sequencing, has acquired Molegro for an undisclosed amount. Molegro provides software for molecular docking, including the prediction and analysis of protein-ligand interactions, screening of compound databases for activities against a receptor and determination of molecule similarity. CLC bio stated that the acquisition supported its strategy […]
In May, Pacific Biosciences introduced new analysis software for its PacBio RS High Resolution Genetic Analyzer to detect epigenetics modifications, which can provide information on biological processes such as aging, disease development and immunity. The new software measures the kinetics of base addition during sequencing, which allows for sequencing of a variety of base modifications, […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
